Cartesian Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Cartesian Therapeutics, Inc. (RNAC) had Common Stock, Capital Shares Reserved for Future Issuance of 13.52 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-06
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 13.52M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 13.08M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 12.30M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 12.31M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 13.52M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 13.08M shares 10-Q · filed 2026-04-30 |
| 2025-12-31 | 12.30M shares 10-K · filed 2026-03-09 |
| 2025-09-30 | 12.31M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 12.31M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 12.37M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 11.51M shares 10-K · filed 2025-03-13 |
| 2024-09-30 | 13.22M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 12.79M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 21.27M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 90.37M shares 10-K · filed 2024-03-07 |
| 2023-09-30 | 61.74M shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 63.17M shares 10-Q · filed 2023-08-17 |
| 2023-03-31 | 61.83M shares 10-Q · filed 2023-05-04 |
| 2022-12-31 | 54.56M shares 10-K · filed 2023-03-02 |
| 2022-09-30 | 54.57M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 54.69M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 34.21M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 28.21M shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 30.07M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 30.11M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 30.93M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 25.16M shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 26.71M shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 27.76M shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 44.39M shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 40.17M shares 10-K · filed 2021-03-12 |
| 2019-09-30 | 8.88M shares 10-Q · filed 2019-11-08 |
| 2019-06-30 | 8.95M shares 10-Q · filed 2019-08-08 |
| 2019-03-31 | 8.95M shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 5.95M shares 10-K · filed 2020-03-12 |
| 2018-09-30 | 6.07M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 4.93M shares 10-Q · filed 2018-08-08 |
| 2018-03-31 | 4.75M shares 10-Q · filed 2018-05-09 |
| 2017-12-31 | 3.76M shares 10-K · filed 2019-03-15 |
| 2017-09-30 | 3.91M shares 10-Q · filed 2017-11-07 |
| 2017-06-30 | 3.95M shares 10-Q · filed 2017-08-11 |
| 2017-03-31 | 3.98M shares 10-Q · filed 2017-05-11 |
| 2016-12-31 | 3.16M shares 10-K · filed 2018-03-15 |
| 2016-09-30 | 3.04M shares 10-Q · filed 2016-11-10 |
| 2016-06-30 | 3.05M shares 10-Q · filed 2016-08-09 |
| 2015-12-31 | 12.83M shares 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |